Loading

Switching space...

Please wait while we prepare your workspace

Startup Image

Braintale

France, Strasbourg

Visit website

BrainTale provides sensitive, reliable, clinically validated and easily accessible biomarkers to accelerate Central Nervous System (CNS) drugs development and optimize patient care. They focus on white matter understanding to improve disease diagnosis, accelerate new therapies, and support decision-making in neurology for conditions like Alzheimer's, Multiple Sclerosis, and Coma.

Follow Braintale
FOUNDATION
YEAR
2017
EMPLOYEESN/A
AVERAGE AGEN/A